noom.semaglutide Noom expands its GLP-1 range with 'microdose' package Noom launches Proactive Health GLP-1

The main points are briefly summarised in these bullet points below, provided by Viking Therapeutics earnings press release: Oral VK2735 to Advance into Phase 3 for Obesity in 3Q26 Phase 3 VANQUISH Trials for Subcutaneous VK2735 in Obesity Ongoing

Ozempic starts at 0.25 mg, before doubling every four weeks until you reach the most potent strength of 2 mg per week

lifestyle, timing, and provider oversight remain essential

For example, research by van Bloemendaal et al

Below, Ill share my personal experience as a Certified Nutrition Coach (CNC) and Certified Personal Trainer (CPT) on Tirzepatide, as well as high protein meals, foods to avoid, easy recipes, and practical tips to support healthy weight loss

They upset hormones and metabolism, courting bigger long-term problems